PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation. - Anderson GR; Wardell SE; Cakir M; Crawford L; Leeds JC; Nussbaum DP; Shankar PS; Soderquist RS; Stein EM; Tingley JP; Winter PS; Zieser-Misenheimer EK; et al. (Science translational medicine, 2016)